News & Trends - MedTech & Diagnostics
Keyhole surgery in cervical cancer carries higher risk of death than open surgery

MedTech News: Minimally invasive techniques are increasingly common in cancer surgery. A recent trial has brought into question the safety of minimally invasive radical hysterectomy for cervical cancer.
In this systematic review and meta-analysis, researchers analysed the data from 15 previous studies, including a total of 9,499 patients, and say minimally-invasive ‘keyhole’ hysterectomies were associated with an increased risk of death among women with cervical cancer, compared with open surgery.
Women who underwent the keyhole procedure died sooner than those who underwent open surgery, and the disease was more likely to return, say the authors.
The pooled hazard of recurrence or death was 71% higher among patients who underwent minimally invasive radical hysterectomy compared with those who underwent open surgery (hazard ratio [HR], 1.71; 95% CI, 1.36-2.15; P < .001), and the hazard of death was 56% higher (HR, 1.56; 95% CI, 1.16-2.11; P = .004).
According to the authors, no association was found between the prevalence of robot-assisted surgery and the magnitude of association between minimally invasive radical hysterectomy and hazard of recurrence or death.
The findings support the survival benefits of undergoing full, open hysterectomy for early-stage cervical cancer.
Register & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
You may also like Key recommendations for data access to modernise Australia’s healthcare system post COVID-19 – Podcast
News & Trends - Pharmaceuticals

Did the Federal Budget deliver for health?
Health is the Federal Government’s largest financial commitment outside social welfare, absorbing approximately 15% of taxpayer funds. Yet, tonight’s Budget […]
MoreNews & Trends - Pharmaceuticals

How can the government Close the Gap with forecasted decline in funding?
The Federal Government will increase investment in First Nations health programs by just 2.8% to $1.4 billion in 2025-26 – […]
MoreNews & Trends - Biotechnology

Local biotech kicks off phase 3 trial for lung cancer combination therapy
ASX-listed biotech company Immutep has reached a major milestone, announcing that the first patient has been successfully dosed in its […]
MoreMedical and Science

Research on life support as government Budget fails to deliver critical funding
Stakeholders are voicing disappointment over the government’s Budget failure to at least maintain research funding in line with inflation. In […]
More